Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Absolute Lymphocyte Count”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Testing effectiveness (Phase 2)Ended earlyNCT02384954
What this trial is testing

QUILT-3.002: N-803 in Patients With Relapse/Refractory iNHL in Conjunction With Rituximab

Who this might be right for
Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphoma
Altor BioScience 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07783789
What this trial is testing

NAI (Nogapendekin Alfa Inbakicept) Plus Standard of Care in Critically Ill Adults With Sepsis

Who this might be right for
SepsisSeptic Shock
ImmunityBio, Inc. 49
Testing effectiveness (Phase 2)Ended earlyNCT02797431
What this trial is testing

Immune Reconstitution of Immunosuppressed Sepsis Patients

Who this might be right for
Severe Sepsis With Septic Shock
University Hospital, Limoges 16
Not applicableStudy completedNCT05976204
What this trial is testing

Prognostic Value of NLR, TLR, and ALC in Predicting ToF Primary Repair Outcome

Who this might be right for
Congenital Heart DiseaseTetralogy of FallotNeutrophil-lymphocyte Ratio+4 more
National Cardiovascular Center Harapan Kita Hospital Indonesia 501
Not applicableStudy completedNCT00002307
What this trial is testing

A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Not applicableAvailableNCT06956547
What this trial is testing

Expanded Access Use of Nogapendekin-alfa Inbakicept in the Reversal and Maintenance of Absolute Lymphocyte Count (ALC) for the Treatment of Lymphopenia Induced by Chemotherapy, Immunotherapy, and/or Radiation Therapy

Who this might be right for
Lymphopenia
ImmunityBio, Inc.
Testing effectiveness (Phase 2)Study completedNCT02640807
What this trial is testing

IL-7 to Restore Absolute Lymphocyte Counts in Sepsis Patients

Who this might be right for
Severe Sepsis With Septic Shock
Revimmune 27
Early research (Phase 1)Ended earlyNCT02099539
What this trial is testing

QUILT-3.005: A Study of N-803 in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Altor BioScience 19
Very early researchStudy completedNCT04781309
What this trial is testing

NT-I7, a Long-Acting Recombinant IL-7 Molecule, as an Immune Reconstitution Strategy for Lymphopenia in Patients With Progressive Multifocal Leukoencephalopathy

Who this might be right for
Progressive Multifocal Leukoencephalopathy
National Institute of Neurological Disorders and Stroke (NINDS) 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT02570542
What this trial is testing

Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)Relapsed Diffuse Large B-cell Lymphoma (DLBCL)Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Memorial Sloan Kettering Cancer Center 59
Testing effectiveness (Phase 2)Ended earlyNCT03821038
What this trial is testing

Recombinant Interleukin-7 (CYT107) to Restore Absolute Lymphocyte Counts in Sepsis Patients

Who this might be right for
Sepsis, Severe
Revimmune 21